|
Aug 9
|
New to The Street to Air Show #683 on Bloomberg, Featuring BioVie, FLOKI, PetVivo, and NRx Pharmaceuticals
|
|
Aug 7
|
PetVivo Sets Fiscal First Quarter 2026 Conference Call for Thursday, August 14, 2025 at 5:00 p.m. ET
|
|
Aug 3
|
New to The Street TV Commercial Campaigns Achieve Millions of Views with 87% Average Completion Rate
|
|
Aug 1
|
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustainable Green ...
|
|
Jul 30
|
PetVivo Holdings Inc. to Trade on OTCQX Best Market
|
|
Jul 30
|
OTC Markets Group Welcomes PetVivo Holdings Inc. to OTCQX
|
|
Jun 30
|
PetVivo Reports Fiscal 2025 Results
|
|
Jun 26
|
PetVivo Sets Fiscal Fourth Quarter 2025 Conference Call for Monday, June 30 at 5:00 p.m. ET
|
|
Jun 24
|
PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF PURCHASE OPTION TIED TO SERIES B CONVERTIBLE PREFERRED STOCK OFFERING
|
|
Jun 14
|
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
|
|
May 22
|
Petvivo Holdings, Inc. and PiezoBioMembrane Inc. Announce Master Services Agreement to Jointly Develop Innovative Functional Biomaterials
|
|
Jan 27
|
PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor
|
|
Dec 30
|
PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025
|
|
Aug 27
|
PetVivo Teams with Orthobiologic Innovations for Clincial Research and Product Commercialization
|
|
Jun 25
|
PetVivo Sets Fiscal Fourth Quarter 2024 Conference Call for Friday, June 28 at 5:00 p.m. ET
|
|
Feb 14
|
PetVivo Holdings Third Quarter 2024 Earnings: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)
|
|
Feb 13
|
PetVivo Holdings, Inc. (NASDAQ:PETV) Q3 2024 Earnings Call Transcript
|
|
Feb 13
|
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
|
|
Feb 7
|
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
|
|
Feb 6
|
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
|